In the News

1851 News Items found
Harold Varmus
Memorial Sloan Kettering Cancer Center President Harold Varmus was awarded the 2008 Henry G. Friesen International Prize in Health Research on September 24 in Toronto.
Eric G. Pamer
Memorial Sloan Kettering researchers have found a way to restore innate immune defense in the intestines and enhance resistance to a potentially harmful antibiotic-resistant bacterium.
Kathryn Anderson
Kathryn V. Anderson has been elected a member of the Institute of Medicine of the National Academies.
(From left) David Scheinberg, Andrew Zelenetz, and Joseph Jurcic are using monoclonal antibodies to improve the treatment of patients with leukemia and lymphoma.
Therapies designed to target cancer while sparing healthy tissue show benefit, but have not yet reached full potential.
Investigators at Memorial Sloan Kettering Cancer Center have found new clues about how metastatic cancer can form long after a primary tumor has been removed.
Memorial Sloan Kettering researchers gathered with scientists from four other institutions at Cold Spring Harbor Laboratory on Long Island in September to present and discuss projects funded by the Starr Cancer Consortium.
Alan Houghton with Pathologist Kay Park, Chair of the Junior Faculty Council
Alan Houghton Receives Mentorship Award
Memorial Sloan Kettering's Junior Faculty Council presented its 2008 Award for Excellence in Mentoring to Alan N. Houghton, Vice Chair for Academic Affairs in the Department of Medicine and incumbent of the Virginia and Daniel K. Ludwig Clinical Chair.
Michael Glickman
An Interview with Michael Glickman
Physician-scientist Michael S. Glickman specializes in the treatment and study of infectious diseases.
(Left to right) Medical oncologist Mark Robson, gynecologist Noah Kauff, medical oncologist Zsofia Stadler, and Clinical Genetics Service Chief Kenneth Offit are applying genetic insights to improve the care of cancer patients.
At Memorial Sloan Kettering, as the genetics revolution continues to flourish, discoveries made in the laboratory are increasingly producing real-world benefits for cancer patients.
Investigators at Memorial Sloan Kettering have developed a new tool that could help them advance the understanding of human embryonic stem cells.